Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
KFSH Conducts Nearly Half of Saudi Arabia's Registered Clinical Trials as Research Infrastructure Expands
1+ hour, 3+ min ago (105+ words) EIN Presswire There were 180 press releases posted in the last 24 hours and 485,982 in the last 365 days. KFSH Conducts Nearly Half of Saudi Arabia's Registered Clinical Trials as Research Infrastructure Expands EIN Presswire provides this news content "as is" without warranty…...
New partnership to strengthen CAR-T cell therapy manufacturing capabilities in Japan
2+ hour, 8+ min ago (258+ words) BioSpectrum Asia New partnership to strengthen CAR-T cell therapy manufacturing capabilities in Japan September 13, 2026 | Sunday | News Teijin, Teijin Regenet and Shinshu University Hospital to contribute to the advancement of cell and gene therapies in Japan Teijin Limited, Teijin Regenet Co.,…...
A New Super-Resolution Microscopy Technique Lets Scientists Study Cells In Real Time
4+ hour, 33+ min ago (340+ words) A new fluorescence microscopy technique promises to create super-resolution images from a single exposure and give scientists a remarkable look inside cells. The technique, reported by Phys, is called SPIFFI. This stands for spatial polarization-induced fluorescence fluctuation imaging, as researchers…...
Biological Computing: More Than a Reaction
2+ hour, 11+ min ago (28+ words) There is something about the language we use around technology that can make extraordinary things sound remarkably ordinary. Inputs, outputs, feedback loops …...
Best AI Tools for Medical Researchers 2026
7+ hour, 17+ min ago (1233+ words) Medically reviewed by Dr. Abishek Shahi, Harvard-trained Physician · Last reviewed September 13, 2026 EvidenceMD is the best AI tool for medical researchers in 2026 when the work is interpreting clinical evidence. It is a fine-tuned clinical reasoning model that spends up to 64,000 reasoning…...
Medical breakthroughs rely on the government protecting intellectual property | Opinion
8+ hour, 26+ min ago (591+ words) When doctors diagnosed former U.S. Sen. Ben Sasse with late-stage pancreatic cancer last year, they gave him just 90 days to live. But more than halfway through 2026, he’s still actively touring the country — and just announced that his tumors have shrunk 80% — thanks…...
Scientists found a new way aging cells may hide from the immune system — and it could point to future treatments
11+ hour, 53+ min ago (776+ words) Some worn-out cells don't quietly retire. They linger in tissues, release inflammatory signals and may make it harder for neighboring cells to function normally. Scientists call them senescent cells, and their accumulation with age has made them a major target…...
SaveTheLife: The Real Moat in Health DePIN May Be the Boring Stuff
4+ hour, 3+ min ago (1639+ words) The future of Health DePIN may not be won by the project with the loudest token narrative. It may be won by the team that gets the boring parts right. None of these things sound particularly exciting on Crypto Twitter....
Chad Rusthoven, MD, of the University of Colorado School of Medicine [IMAGE] | EurekAlert! Science News Releases
12+ hour, 53+ min ago (46+ words) Chad Rusthoven, MD, of the University of Colorado School of Medicine (IMAGE) EurekAlert! Chad Rusthoven, MD, of the University of Colorado School of Medicine More on this News Release Phase III MAVERICK trial supports brain MRI surveillance alone as standard…...
Giannis Mountzios, M.D., of the Henry Dunant Hospital Center, Athens, Greece [IMAGE] | EurekAlert! Science News Releases
11+ hour, 40+ min ago (43+ words) Giannis Mountzios, M.D., of the Henry Dunant Hospital Center, Athens, Greece (IMAGE) EurekAlert! Giannis Mountzios, M.D., of the Henry Dunant Hospital Center, Athens, Greece More on this News Release Sacituzumab govitecan plus pembrolizumab does not meet primary endpoints in first-line PD-L1-high…...